ARVINAS INC (ARVN) Fundamental Analysis & Valuation

NASDAQ:ARVN • US04335A1051

Current stock price

11 USD
0 (0%)
At close:
11.22 USD
+0.22 (+2%)
After Hours:

This ARVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ARVN Profitability Analysis

1.1 Basic Checks

  • ARVN had negative earnings in the past year.
  • ARVN had a negative operating cash flow in the past year.
  • ARVN had negative earnings in each of the past 5 years.
  • ARVN had negative operating cash flow in 4 of the past 5 years.
ARVN Yearly Net Income VS EBIT VS OCF VS FCFARVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M

1.2 Ratios

  • ARVN has a better Return On Assets (-11.26%) than 66.49% of its industry peers.
  • With a decent Return On Equity value of -18.62%, ARVN is doing good in the industry, outperforming 69.11% of the companies in the same industry.
Industry RankSector Rank
ROA -11.26%
ROE -18.62%
ROIC N/A
ROA(3y)-19.21%
ROA(5y)-18.39%
ROE(3y)-36.56%
ROE(5y)-36.83%
ROIC(3y)N/A
ROIC(5y)N/A
ARVN Yearly ROA, ROE, ROICARVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5K -10K

1.3 Margins

  • ARVN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARVN Yearly Profit, Operating, Gross MarginsARVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ARVN Health Analysis

2.1 Basic Checks

  • ARVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ARVN has less shares outstanding
  • Compared to 5 years ago, ARVN has more shares outstanding
  • Compared to 1 year ago, ARVN has a worse debt to assets ratio.
ARVN Yearly Shares OutstandingARVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
ARVN Yearly Total Debt VS Total AssetsARVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of -0.89, we must say that ARVN is in the distress zone and has some risk of bankruptcy.
  • ARVN has a Altman-Z score (-0.89) which is in line with its industry peers.
  • ARVN has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • ARVN's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. ARVN outperforms 60.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.89
ROIC/WACCN/A
WACC9.3%
ARVN Yearly LT Debt VS Equity VS FCFARVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

2.3 Liquidity

  • ARVN has a Current Ratio of 4.92. This indicates that ARVN is financially healthy and has no problem in meeting its short term obligations.
  • ARVN's Current ratio of 4.92 is fine compared to the rest of the industry. ARVN outperforms 64.92% of its industry peers.
  • ARVN has a Quick Ratio of 4.92. This indicates that ARVN is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.92, ARVN is in the better half of the industry, outperforming 66.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.92
Quick Ratio 4.92
ARVN Yearly Current Assets VS Current LiabilitesARVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ARVN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 53.79% over the past year.
  • ARVN shows a decrease in Revenue. In the last year, the revenue decreased by -0.30%.
  • The Revenue has been growing by 64.50% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)53.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.6%
Revenue 1Y (TTM)-0.3%
Revenue growth 3Y25.96%
Revenue growth 5Y64.5%
Sales Q2Q%-83.95%

3.2 Future

  • ARVN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.85% yearly.
  • The Revenue is expected to decrease by -0.58% on average over the next years.
EPS Next Y-173.36%
EPS Next 2Y-67.57%
EPS Next 3Y-18.41%
EPS Next 5Y14.85%
Revenue Next Year-68.71%
Revenue Next 2Y-49.95%
Revenue Next 3Y-18.43%
Revenue Next 5Y-0.58%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ARVN Yearly Revenue VS EstimatesARVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
ARVN Yearly EPS VS EstimatesARVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15 -20 -25

More info and screens

Find the best growth stocksShow best growing peers

0

4. ARVN Valuation Analysis

4.1 Price/Earnings Ratio

  • ARVN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ARVN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARVN Price Earnings VS Forward Price EarningsARVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARVN Per share dataARVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

  • ARVN's earnings are expected to decrease with -18.41% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-67.57%
EPS Next 3Y-18.41%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ARVN Dividend Analysis

5.1 Amount

  • ARVN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARVN Fundamentals: All Metrics, Ratios and Statistics

ARVINAS INC

NASDAQ:ARVN (4/17/2026, 8:00:02 PM)

After market: 11.22 +0.22 (+2%)

11

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-24
Earnings (Next)04-30
Inst Owners88.33%
Inst Owner Change0.07%
Ins Owners1.29%
Ins Owner Change2.79%
Market Cap703.56M
Revenue(TTM)262.60M
Net Income(TTM)-80.80M
Analysts76.15
Price Target15.54 (41.27%)
Short Float %7.69%
Short Ratio5.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.97%
Min EPS beat(2)-82.67%
Max EPS beat(2)40.73%
EPS beat(4)3
Avg EPS beat(4)48.54%
Min EPS beat(4)-82.67%
Max EPS beat(4)218.09%
EPS beat(8)7
Avg EPS beat(8)42.7%
EPS beat(12)9
Avg EPS beat(12)24.85%
EPS beat(16)9
Avg EPS beat(16)12.59%
Revenue beat(2)1
Avg Revenue beat(2)0.38%
Min Revenue beat(2)-73.3%
Max Revenue beat(2)74.06%
Revenue beat(4)2
Avg Revenue beat(4)79.52%
Min Revenue beat(4)-73.3%
Max Revenue beat(4)345.02%
Revenue beat(8)4
Avg Revenue beat(8)48.53%
Revenue beat(12)6
Avg Revenue beat(12)23.66%
Revenue beat(16)9
Avg Revenue beat(16)23.16%
PT rev (1m)13.6%
PT rev (3m)15.11%
EPS NQ rev (1m)1.35%
EPS NQ rev (3m)-17.62%
EPS NY rev (1m)-4.49%
EPS NY rev (3m)-14.19%
Revenue NQ rev (1m)-1.78%
Revenue NQ rev (3m)-14.32%
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)-2.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.68
P/FCF N/A
P/OCF N/A
P/B 1.62
P/tB 1.62
EV/EBITDA N/A
EPS(TTM)-1.28
EYN/A
EPS(NY)-3.5
Fwd EYN/A
FCF(TTM)-4.31
FCFYN/A
OCF(TTM)-4.28
OCFYN/A
SpS4.11
BVpS6.78
TBVpS6.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -11.26%
ROE -18.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-19.21%
ROA(5y)-18.39%
ROE(3y)-36.56%
ROE(5y)-36.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 63.33%
Cap/Sales 0.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.92
Quick Ratio 4.92
Altman-Z -0.89
F-Score5
WACC9.3%
ROIC/WACCN/A
Cap/Depr(3y)54.29%
Cap/Depr(5y)73.75%
Cap/Sales(3y)1.7%
Cap/Sales(5y)4.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.6%
EPS Next Y-173.36%
EPS Next 2Y-67.57%
EPS Next 3Y-18.41%
EPS Next 5Y14.85%
Revenue 1Y (TTM)-0.3%
Revenue growth 3Y25.96%
Revenue growth 5Y64.5%
Sales Q2Q%-83.95%
Revenue Next Year-68.71%
Revenue Next 2Y-49.95%
Revenue Next 3Y-18.43%
Revenue Next 5Y-0.58%
EBIT growth 1Y53.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-146.32%
EBIT Next 3Y-18.5%
EBIT Next 5YN/A
FCF growth 1Y-5.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.59%
OCF growth 3YN/A
OCF growth 5YN/A

ARVINAS INC / ARVN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ARVINAS INC (ARVN) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ARVN.


Can you provide the valuation status for ARVINAS INC?

ChartMill assigns a valuation rating of 0 / 10 to ARVINAS INC (ARVN). This can be considered as Overvalued.


What is the profitability of ARVN stock?

ARVINAS INC (ARVN) has a profitability rating of 1 / 10.


What is the financial health of ARVINAS INC (ARVN) stock?

The financial health rating of ARVINAS INC (ARVN) is 4 / 10.